Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Seeing how we smell.

Benveniste H, Lazebnik Y, Volkow ND.

J Clin Invest. 2017 Feb 1;127(2):447-449. doi: 10.1172/JCI91305. Epub 2017 Jan 23.

3.

Comment on: 'guidelines for the use of cell lines in biomedical research': human-to-human cancer transmission as a laboratory safety concern.

Lazebnik Y, Parris GE.

Br J Cancer. 2015 Jun 9;112(12):1976-7. doi: 10.1038/bjc.2014.656. Epub 2015 Jan 13. No abstract available.

4.

The shock of being united and symphiliosis. Another lesson from plants?

Lazebnik Y.

Cell Cycle. 2014;13(15):2323-9. doi: 10.4161/cc.29704. No abstract available.

5.

The problem of colliding networks and its relation to cell fusion and cancer.

Koulakov AA, Lazebnik Y.

Biophys J. 2012 Nov 7;103(9):2011-20. doi: 10.1016/j.bpj.2012.08.062.

6.

V-fusion: a convenient, nontoxic method for cell fusion.

Gottesman A, Milazzo J, Lazebnik Y.

Biotechniques. 2010 Oct;49(4):747-50. doi: 10.2144/000113515.

PMID:
20964635
7.

What are the hallmarks of cancer?

Lazebnik Y.

Nat Rev Cancer. 2010 Apr;10(4):232-3. doi: 10.1038/nrc2827.

PMID:
20355252
8.

Cell-to-cell fusion as a link between viruses and cancer.

Duelli D, Lazebnik Y.

Nat Rev Cancer. 2007 Dec;7(12):968-76. doi: 10.1038/nrc2272. Review.

PMID:
18034186
9.

Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells.

Yuneva M, Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y.

J Cell Biol. 2007 Jul 2;178(1):93-105.

10.

A virus causes cancer by inducing massive chromosomal instability through cell fusion.

Duelli DM, Padilla-Nash HM, Berman D, Murphy KM, Ried T, Lazebnik Y.

Curr Biol. 2007 Mar 6;17(5):431-7. Epub 2007 Feb 22.

11.

Requirement of cytochrome c for apoptosis in human cells.

Matapurkar A, Lazebnik Y.

Cell Death Differ. 2006 Dec;13(12):2062-7. Epub 2006 May 26.

12.

A primate virus generates transformed human cells by fusion.

Duelli DM, Hearn S, Myers MP, Lazebnik Y.

J Cell Biol. 2005 Nov 7;171(3):493-503.

13.

Apaf-1 expression in malignant melanoma.

Soengas MS, Gerald WL, Cordon-Cardo C, Lazebnik Y, Lowe SW.

Cell Death Differ. 2006 Feb;13(2):352-3. No abstract available.

14.

Can a biologist fix a radio? -- Or, what I learned while studying apoptosis, (Cancer Cell. 2002 Sep;2(3):179-82).

Lazebnik Y.

Biochemistry (Mosc). 2004 Dec;69(12):1403-6. No abstract available.

15.
16.

Components of the cell death machine and drug sensitivity of the National Cancer Institute Cell Line Panel.

Svingen PA, Loegering D, Rodriquez J, Meng XW, Mesner PW Jr, Holbeck S, Monks A, Krajewski S, Scudiero DA, Sausville EA, Reed JC, Lazebnik YA, Kaufmann SH.

Clin Cancer Res. 2004 Oct 15;10(20):6807-20.

17.

A sense of life: computational and experimental investigations with models of biochemical and evolutionary processes.

Mishra B, Daruwala RS, Zhou Y, Ugel N, Policriti A, Antoniotti M, Paxia S, Rejali M, Rudra A, Cherepinsky V, Silver N, Casey W, Piazza C, Simeoni M, Barbano P, Spivak M, Feng J, Gill O, Venkatesh M, Cheng F, Sun B, Ioniata I, Anantharaman T, Hubbard EJ, Pnueli A, Harel D, Chandru V, Hariharan R, Wigler M, Park F, Lin SC, Lazebnik Y, Winkler F, Cantor CR, Carbone A, Gromov M.

OMICS. 2003 Fall;7(3):253-68.

PMID:
14583115
18.

Cell fusion: a hidden enemy?

Duelli D, Lazebnik Y.

Cancer Cell. 2003 May;3(5):445-8. No abstract available.

19.

The major apoptotic pathway activated and suppressed by poliovirus.

Belov GA, Romanova LI, Tolskaya EA, Kolesnikova MS, Lazebnik YA, Agol VI.

J Virol. 2003 Jan;77(1):45-56.

20.

Direct coupling of the cell cycle and cell death machinery by E2F.

Nahle Z, Polakoff J, Davuluri RV, McCurrach ME, Jacobson MD, Narita M, Zhang MQ, Lazebnik Y, Bar-Sagi D, Lowe SW.

Nat Cell Biol. 2002 Nov;4(11):859-64.

PMID:
12389032
21.

Can a biologist fix a radio?--Or, what I learned while studying apoptosis.

Lazebnik Y.

Cancer Cell. 2002 Sep;2(3):179-82. No abstract available.

22.

Confirming specificity of RNAi in mammalian cells.

Lassus P, Rodriguez J, Lazebnik Y.

Sci STKE. 2002 Aug 27;2002(147):pl13.

PMID:
12198178
23.

Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization.

Lassus P, Opitz-Araya X, Lazebnik Y.

Science. 2002 Aug 23;297(5585):1352-4.

24.

Expression and transcriptional regulation of caspase-14 in simple and complex epithelia.

Pistritto G, Jost M, Srinivasula SM, Baffa R, Poyet JL, Kari C, Lazebnik Y, Rodeck U, Alnemri ES.

Cell Death Differ. 2002 Sep;9(9):995-1006.

25.

Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction.

Hegde R, Srinivasula SM, Zhang Z, Wassell R, Mukattash R, Cilenti L, DuBois G, Lazebnik Y, Zervos AS, Fernandes-Alnemri T, Alnemri ES.

J Biol Chem. 2002 Jan 4;277(1):432-8. Epub 2001 Oct 17.

26.

Why do regulators of apoptosis look like bacterial toxins?

Lazebnik Y.

Curr Biol. 2001 Oct 2;11(19):R767-8. Review. No abstract available.

27.

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma.

Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordón-Cardó C, Lowe SW.

Nature. 2001 Jan 11;409(6817):207-11.

PMID:
11196646
28.

Evaluation of Apaf-1 and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemia.

Svingen PA, Karp JE, Krajewski S, Mesner PW Jr, Gore SD, Burke PJ, Reed JC, Lazebnik YA, Kaufmann SH.

Blood. 2000 Dec 1;96(12):3922-31.

29.

Caspases disrupt the nuclear-cytoplasmic barrier.

Faleiro L, Lazebnik Y.

J Cell Biol. 2000 Nov 27;151(5):951-9.

30.

Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation.

Zheng TS, Hunot S, Kuida K, Momoi T, Srinivasan A, Nicholson DW, Lazebnik Y, Flavell RA.

Nat Med. 2000 Nov;6(11):1241-7.

PMID:
11062535
31.

Primary cells suppress oncogene-dependent apoptosis.

Duelli DM, Lazebnik YA.

Nat Cell Biol. 2000 Nov;2(11):859-62.

PMID:
11056544
32.

Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins.

Bellows DS, Chau BN, Lee P, Lazebnik Y, Burns WH, Hardwick JM.

J Virol. 2000 Jun;74(11):5024-31.

33.

Caspase-9 and APAF-1 form an active holoenzyme.

Rodriguez J, Lazebnik Y.

Genes Dev. 1999 Dec 15;13(24):3179-84.

34.

Crystal structure of Apaf-1 caspase recruitment domain: an alpha-helical Greek key fold for apoptotic signaling.

Vaughn DE, Rodriguez J, Lazebnik Y, Joshua-Tor L.

J Mol Biol. 1999 Oct 29;293(3):439-47.

PMID:
10543941
35.

Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c.

Kirsch DG, Doseff A, Chau BN, Lim DS, de Souza-Pinto NC, Hansford R, Kastan MB, Lazebnik YA, Hardwick JM.

J Biol Chem. 1999 Jul 23;274(30):21155-61.

36.

Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis.

Srinivasula SM, Ahmad M, Guo Y, Zhan Y, Lazebnik Y, Fernandes-Alnemri T, Alnemri ES.

Cancer Res. 1999 Mar 1;59(5):999-1002.

37.

Oncogene-dependent apoptosis is mediated by caspase-9.

Fearnhead HO, Rodriguez J, Govek EE, Guo W, Kobayashi R, Hannon G, Lazebnik YA.

Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13664-9.

38.

Caspases: enemies within.

Thornberry NA, Lazebnik Y.

Science. 1998 Aug 28;281(5381):1312-6. Review.

PMID:
9721091
39.

Oncogene-dependent apoptosis in extracts from drug-resistant cells.

Fearnhead HO, McCurrach ME, O'Neill J, Zhang K, Lowe SW, Lazebnik YA.

Genes Dev. 1997 May 15;11(10):1266-76.

40.

Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells.

Faleiro L, Kobayashi R, Fearnhead H, Lazebnik Y.

EMBO J. 1997 May 1;16(9):2271-81.

41.

Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis.

Takahashi A, Alnemri ES, Lazebnik YA, Fernandes-Alnemri T, Litwack G, Moir RD, Goldman RD, Poirier GG, Kaufmann SH, Earnshaw WC.

Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8395-400.

42.

Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution.

Lazebnik YA, Takahashi A, Moir RD, Goldman RD, Poirier GG, Kaufmann SH, Earnshaw WC.

Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9042-6.

43.

Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis.

Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, et al.

Nature. 1995 Jul 6;376(6535):37-43.

PMID:
7596430
44.

Characterization of the execution phase of apoptosis in vitro using extracts from condemned-phase cells.

Lazebnik YA, Takahashi A, Poirier GG, Kaufmann SH, Earnshaw WC.

J Cell Sci Suppl. 1995;19:41-9.

PMID:
8655646
45.

Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE.

Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC.

Nature. 1994 Sep 22;371(6495):346-7.

PMID:
8090205
46.
47.

Drop-delay measurement using enzyme-coated particles.

Lazebnik YA, Poletaev AI, Zenin VV.

Cytometry. 1992;13(6):649-52.

48.

Reversible G2 block in the cell cycle of Ehrlich ascites carcinoma cells.

Lazebnik YA, Medvedeva ND, Zenin VV.

Exp Cell Res. 1991 Jul;195(1):247-54.

PMID:
2055271
49.

PHEOCHROMOCYTOMA AND PREGNANCY: SIMULTANEOUS DELIVERY BY CESAREAN SECTION AND RESECTION OF TUMOR.

BARZEL US, BAR-ILAN Z, RUMNEY G, LAZEBNIK Y, ECKERLING B, DEVRIES A.

Am J Obstet Gynecol. 1964 Jun 15;89:519-27. No abstract available.

PMID:
14168991
50.

[A case of the urachus tumor].

LAZEBNIK Y, KAMHI D.

Urol Int. 1959;8:25-32. French. No abstract available.

PMID:
14414815

Supplemental Content

Loading ...
Support Center